As people with polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS) approach the end of their reproductive years, cycles tend to become more regular and more often ovulatory, the ovarian appearance seen on ultrasound fades, and androgen levels fall. Some people stop meeting the diagnostic criteria as a result, but there are currently no diagnostic criteria for PMOS after menopause. Metabolic health is still worth discussing with a clinician.
Key takeaways
- Cycles often settle. Toward the end of reproductive life, cycles in PMOS tend to become more regular and more often ovulatory.
- The ovarian appearance usually fades. Ovarian volume and follicle count fall with age, and the polycystic appearance is lost in most people.
- Androgen levels decline. They fall gradually from a person’s 20s onward, and androgen excess tends to ease.
- The diagnosis gets harder to apply. Some people no longer meet the criteria, and there are currently no diagnostic criteria for PMOS after menopause.
- Metabolic health is still worth discussing. The guideline doesn’t limit its attention to metabolic health to the reproductive years.
What changes with PMOS after 40, and what doesn’t?
Here’s a quick summary of what the research describes.
| Feature | What tends to happen with age | What it means for you |
|---|---|---|
| Cycles | More regular and more often ovulatory | Fewer of the irregular cycles that may have been part of your diagnosis |
| Ovarian appearance on ultrasound | Fades, and is lost in most people | One diagnostic feature can disappear through aging alone |
| Androgen levels | Decline gradually from your 20s onward | Androgen excess tends to ease |
| Diagnostic criteria | No agreed criteria after menopause | Whether the diagnosis still applies is an open question |
| Metabolic health | Still part of the guideline’s long-term picture | Worth checking in on with a clinician |
Do PMOS cycles get more regular after 40?
For many people, yes, and it’s something most reading on PMOS doesn’t prepare you for. A 2022 review by Nafiye Helvaci and Bulent Okan Yildiz in Clinical Endocrinology describes cycles in PMOS becoming more regular and more often ovulatory toward the end of reproductive life. It’s a documented pattern, not just an impression.
The reason ties back to androgens. Androgen excess interferes with follicle maturation, and androgen levels decline gradually from a person’s 20s onward. As that pressure eases, the follicle selection step that stalls in PMOS works more often.

What happens to the ovarian appearance with age?
It fades, and in most people it’s lost. Ovarian volume and follicle count fall steadily with reproductive aging, and Helvaci and Yildiz report that this leads to the loss of the polycystic ovarian appearance in most people with the condition.
That has a practical consequence: one of the three diagnostic features, the polycystic ovarian appearance, can disappear over time through aging alone.
easy@Home Ovulation Test Strips: LH Test Kit
$9.99$10.99-9%
Does a PMOS diagnosis still apply after menopause?
This is where things are genuinely unsettled. With cycles more regular, androgens lower and the ovarian appearance faded, some people no longer meet criteria they once met. That doesn’t simply mean the condition has gone. It means criteria built around reproductive-age features stop describing someone who’s past their reproductive years.
The honest position is the one the research states: there are currently no diagnostic criteria for PMOS after menopause. So if you’ve been told you no longer have it, or that you definitely still do, both statements go further than the evidence. What your own picture means is a conversation for a clinician who can see all of it.
What doesn’t change after 40?
Metabolic health stays on the table. The 2023 International Evidence-Based Guideline, led by Helena Teede and colleagues, recognizes several long-term health concerns in PMOS, including metabolic risk factors, cardiovascular disease, sleep disorders and psychological health, and it doesn’t frame them as a reproductive-age concern only.
The research on what happens after menopause is still developing. Helvaci and Yildiz note that the limited data available don’t show further worsening of cardiometabolic health after menopause, and that cardiovascular risk in older women with the condition may be closer to that of women without it than once expected. That’s the reframe worth taking from this article. The features that were most visible earlier, like irregular cycles, androgen symptoms and the ovarian appearance, are the ones that soften. The less visible ones, like blood sugar and heart health, are the ones still worth keeping an eye on. That’s not because risk rises with age. It’s because it doesn’t simply switch off when cycles settle.

How can you tell perimenopause and PMOS apart?
Often you can’t from symptoms alone, which is why this stage can be confusing. Both can involve irregular cycles, and both involve hormonal change. If you’ve had PMOS for years and are now entering perimenopause, the two can produce some of the same features, and it’s hard for anyone to say which is causing what without an assessment.
That’s not something to work out on your own. It’s a reasonable thing to raise with a clinician, especially if your cycles have changed in a way that feels different from your usual pattern.

Is cycle tracking still useful during perimenopause?
Yes, but for a different reason than before. A record of your cycle lengths across these years is genuinely useful, because change over time is hard to see from inside it and hard to reconstruct afterward. Logging your period start dates in Premom, a free cycle tracking app, builds that record as you go.
Predictions are a different matter. Any prediction built from cycle history assumes your cycles are fairly stable, and that includes Premom’s. During a transition, cycles are changing rather than stable, so expect fertile window and period estimates to be less useful here, not more. Lean on the history, not the forecast.
Track how your cycles are changing in Premom
When should you talk to a clinician?
Talk with a clinician if:
- Your cycles have changed in a way that feels different from your usual pattern
- You’ve been told your diagnosis no longer applies and want to understand what that means
- You have symptoms and aren’t sure whether they’re from perimenopause, PMOS or both
- Metabolic health hasn’t come up in your appointments recently
Key terms
Perimenopause: The years leading up to menopause, when hormone levels shift and cycles often change.
Menopause: The point when periods have stopped for 12 months in a row.
Androgens: Hormones such as testosterone that all bodies produce. In PMOS, levels or their effects are often higher.
Ovulatory cycle: A cycle in which an egg is released.
Polycystic ovarian morphology: An ovarian appearance on ultrasound with more small follicles than usual. It’s one of the three diagnostic features.
| "Aider les femmes à suivre leur ovulation plus intelligemment" |








